Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1122L |
IGF-I 30-41 acetate(82177-09-1 free base)
Insulin-like Growth Factor I (30-41) acetate |
Others | Others |
IGF-I 30-41 acetate(82177-09-1 free base) (Insulin-like Growth Factor I (30-41) acetate) 是胰岛素样生长因子 I (IGF-I) 的氨基酸 30 至 41 片段。 | |||
TP1122 |
IGF-I (30-41)
Insulin-like Growth Factor I (30-41),IGF-I 30-41 |
||
IGF-I (30-41) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I). | |||
TP1124 |
IGF-I (24-41)
Insulin-like Growth Factor I (24-41),IGF-I 24-41 |
||
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective | |||
TP1121 |
IGF-I (30-41) TFA(82177-09-1,FREE)
Insulin-like Growth Factor I (30-41) (TFA) |
||
IGF-I (30-41) (TFA) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I). | |||
TP1123 |
IGF-I (24-41) TFA (135861-49-3 free base)
Insulin-like Growth Factor I (24-41) (TFA),IGF-I (24-41) TFA |
||
IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth | |||
T2160 |
Suramin Sodium Salt
苏拉明钠,BAY-205,Suramin hexasodium salt,苏拉明钠盐,NF-060 |
Apoptosis; Phosphatase; SARS-CoV; Sirtuin; Reverse Transcriptase; Topoisomerase; Parasite | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; Microbiology/Virology |
Suramin Sodium Salt (BAY-205) 是可逆的竞争性蛋白酪氨酸磷酸酶抑制剂。它抑制 IP5K,是抗寄生虫,抗肿瘤和抗血管生成剂。它是sirtuins 的有效抑制剂,也是 SARS-CoV-2 RNA 依赖性 RNA 聚合酶抑制剂。 | |||
T70568 |
H-1356
|
||
H-1356 is an insulin-like growth factor 1(IGF-I) analog that inhibits autophosphorylation of IGF-I receptor. | |||
TP1361 |
S961 TFA (1083433-49-1 free base)
S961 TFA |
||
S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively. | |||
T73702 |
Mecasermin
|
||
Mecasermin(Human IGF-I; FK 780),一种重组人胰岛素样生长因子I(IGF-I),主要用于研究因生长激素(GH)受体缺陷或GH抑制抗体导致的GH不敏感性而引起的生长障碍。 | |||
T61506 | NBI-31772 hydrate | ||
NBI-31772 hydrate is a powerful inhibitor of the interaction between insulin-like growth factor (IGF) and IGF-binding proteins (IGFBPs). It acts as a nonpeptide ligand, effectively releasing bioactive IGF-I from the IGF-I/IGFBP-3 complex (Ki values for all six human subtypes range from 1-24 nM). This compound demonstrates significant anxiolytic and antidepressant-like effects [1] [2] [3]. | |||
TP1795 |
S961
|
||
S961是一种高亲和力和选择性胰岛素受体(IR)拮抗剂,接近闪烁计数法试验中对HIR-A、HIR-B 和人胰岛素样生长因子I 受体(HIGF-IR)的ic50分别为0.048、0.027和630 nM。 | |||
T76043L |
S961 acetate
|
||
S961 acetate 是一种高亲和力的胰岛素受体 (insulin receptor, IR) 拮抗剂,对 HIR-A,HIR-B 和人胰岛素样生长因子 I 受体 (HIGF-IR) 的 IC50分别为 0.048,0.027 和 630 nM。 | |||
T76043 |
S961 TFA
|
||
S961 TFA为一种与胰岛素受体(insulin receptor, IR)高亲和力相结合的拮抗剂,其IC50值对HIR-A、HIR-B及人胰岛素样生长因子I受体(HIGF-IR)分别为0.048、0.027及630 nM。 | |||
T76012 |
IGF-I (30-41) (TFA)
|
||
IGF-I (30-41) (TFA) 是类胰岛素生长因子I 30 至 41 的氨基酸片段。IGF-I 对生长激素的活性有着重要的作用,但是IGF-I 本身也具有一些自身的特性,如合成代谢、抗氧化、抗炎和细胞保护作用。 | |||
T76014 |
IGF-I (24-41) (TFA)
|
||
IGF-I (24-41) TFA(Insulin-like Growth Factor I (24-41) TFA)是类胰岛素生长因子I的一个氨基酸片段,覆盖24至41位点。作为一种70个氨基酸组成的多肽激素,IGF-I TFA对神经元和神经胶质细胞具有营养作用,而且在调节全身生长激素(GH)活性中扮演关键角色。它还具备合成代谢、抗氧化、抗炎及细胞保护功能,对躯体生长及行为发育调节作用显著。 |